Case Report: Presenting as optic neuritis—a biopsy-proven IgG4 anti-NF155–positive combined central and peripheral demyelination syndrome - Scorecard - MDSpire
Advertisement
Case Report: Presenting as optic neuritis—a biopsy-proven IgG4 anti-NF155–positive combined central and peripheral demyelination syndrome
Clinical Scorecard: Case Study: Optic Neuritis as the Initial Presentation of Biopsy-Confirmed IgG4 Anti-NF155-Positive Combined Central and Peripheral Demyelination Syndrome
At a Glance
Category
Detail
Condition
Key Mechanisms
Linked to IgG4 subclass antibodies targeting neurofascin-155 (NF155), leading to demyelination in both CNS and PNS.
Target Population
Care Setting
Key Highlights
CCPD can present with isolated optic neuritis as the initial manifestation.
Anti-NF155 antibody testing is critical in cases of peripheral neuropathy.
Guideline-Based Recommendations
Diagnosis
Confirm diagnosis through serological testing for anti-NF155 antibodies and histopathological examination.
Management
Initiate aggressive immunomodulation, including corticosteroids and rituximab.
Monitoring & Follow-up
Regular assessment of visual function and neurological status is essential.
Risks
Monitor for steroid dependence and potential relapses.
Patient & Prescribing Data
Young male with severe optic neuritis and demyelinating symptoms.
Initial treatment included intravenous methylprednisolone followed by oral prednisolone, with subsequent transition to corticosteroid pulse therapy and rituximab.
Clinical Best Practices
Conduct thorough neurological examinations and imaging studies in patients with optic neuritis.
Consider anti-NF155 antibody testing in cases of unexplained peripheral neuropathy.
